Similar articles

• Cyclophosphamide pneumonitis.

  Mark GJ, Lehimgar-Zadeh A, Ragsdale BD. Mark GJ, et al. Thorax. 1978 Feb;33(1):89-93. doi: 10.1136/thx.33.1.89. Thorax. 1978. PMID: 644545 Free PMC article.
• Cyclophosphamide therapy and interstitial pulmonary fibrosis.

  Patel AR, Shah PC, Rhee HL, Sassoon H, Rao KP. Patel AR, et al. Cancer. 1976 Oct;38(4):1542-9. doi: 10.1002/1097-0142(197610)38:4<1542::aid-cncr2820380416>3.0.co;2-r. Cancer. 1976. PMID: 1068740
• Pulmonary fibrosis after prolonged treatment with low-dose cyclophosphamide. A case report.

  Abdel Karim FW, Ayash RE, Allam C, Salem PA. Abdel Karim FW, et al. Oncology. 1983;40(3):174-6. doi: 10.1159/000225719. Oncology. 1983. PMID: 6843943
• Lung toxicity associated with cyclophosphamide use. Two distinct patterns.

  Malik SW, Myers JL, DeRemee RA, Specks U. Malik SW, et al. Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1851-6. doi: 10.1164/ajrccm.154.6.8970380. Am J Respir Crit Care Med. 1996. PMID: 8970380 Review.
• [An autopsy case of cyclophophamide-induced interstitial pneumonia].

  Tanaka H, Hirasawa M, Ohshima S, Shimoyama N, Ishidate T, Suzuki A. Tanaka H, et al. Nihon Kyobu Shikkan Gakkai Zasshi. 1990 Dec;28(12):1622-7. Nihon Kyobu Shikkan Gakkai Zasshi. 1990. PMID: 2077209 Review. Japanese.